ACCD - Pangali Forward P/E Accolade, Inc.

Logo korporat perusahaan Accolade, Inc. (ACCD)

Accolade optimizes corporate healthcare through AI-driven navigation, reducing costs for employers. A distributed cloud infrastructure ensures service stability. However, sluggish sales and the risk of corporate budget cuts are creating a liquidity deficit. The change in the company's forward P/E on this chart allows for an assessment of investor expectations, where 0.00 is recorded as the baseline value of the current metric.

ACCD - Prakiraan rega marang bathi Accolade ing rentang 04.07.2022 - 19.04.2025

Ringkesan rincian data analitis Accolade Health (ACCD)

- kuotasi lan prakiraan analis:
Rega saham Accolade|ACCD - Prakiraan gabungan firma investasi
- statistik kapitalisasi pasar:
Kapitalisasi pasar Accolade Inc|ACCD - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham Accolade|ACCD - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku accolade.com|ACCD - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Accolade|ACCD - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Accolade|ACCD - Utang perusahaan|Utang-utang marang kapitalisasi buku Accolade Inc|ACCD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Accolade|Rasio cepet accolade.com
- statistik bathi lan rasio pasar:
ACCD - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Accolade|ACCD - Pangali P/E|Pangali Forward P/E Accolade|ACCD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Accolade Inc|ACCD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Accolade|ACCD - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan accolade.com|ACCD - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Accolade
Analisis umum perusahaan:Accolade, Inc.
Produk mawa merek Accolade

The forward P/E measures the market value of Accolade (ACCD) relative to its expected annual net income, allowing investors to assess the extent of price inflation relative to future earnings. By analyzing the company's current forward P/E, one can determine how effectively investments in recruiting IT specialists and medical analysts convert into profit growth, which defines the overall resilience of the business model.

Analisis perusahaan pesaing

Pangali Forward P/E HIMS|Hinge Health, Inc. - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E TDOC (Teladoc Inc.)|Pangali Forward P/E Talkspace Platform TALK|LifeMD Corp - Pangali Forward P/E|amwell.com (AMWL) - Prakiraan rega marang bathi|MGRX: Pangali Forward P/E|Prakiraan rega marang bathi DarioHealth Corp|Rega marang bathi mangsa ngarep VSee Health Inc|Rasio prakiraan rega marang bathi Mobile-health Corp MNDR|Rega marang bathi mangsa ngarep Biotricity, Inc. (BTCY)|Rega marang bathi mangsa ngarep LYT (lytuscorp.com)|Pangali Forward P/E OTRK (Ontrak)|Pangali Forward P/E SHL Telemedicine Ltd SHLT|Thorne - Pangali Forward P/E